|
Board CommitteesAudit Committee Compensation and Nomination
|
Shareholders Meetings
Notice is hereby given that the extraordinary general meeting of shareholders (the General Meeting) of TME Pharma N.V. (the Company) is convened at 13.30 hours (CEST) on 30 September 2024 at the offices of Freshfields Bruckhaus Deringer LLP, Strawinskylaan 10, 1077 XZ in Amsterdam, the Netherlands. The language of the meeting shall be English.
The full agenda for the meeting as well as all ancillary documents relevant for the meeting are available for download below.
Downloads
| 2024 EGM Notice and Agenda |  |
| 2024 EGM Attendance Notice and PoA |  |
| Presentation of the AGM (with voting results) held on June 27, 2024 | |
| Minutes of the AGM held on June 27, 2024 | |
Notice is hereby given that the annual general meeting of shareholders (the General Meeting) of TME Pharma N.V. (the Company) is convened at 13.30 hours (CEST) on 27 June 2024 at the offices of Freshfields Bruckhaus Deringer LLP, Strawinskylaan 10, 1077 XZ in Amsterdam, the Netherlands. The language of the meeting shall be English.
The full agenda for the meeting as well as all ancillary documents relevant for the meeting are available for download below.
Downloads
| 2024 AGM Notice and Agenda | |
| 2024 AGM Attendance Notice and PoA | |
| 2024 AGM Agenda item 5 partial amendment AoA NL | |
| 2024 AGM Agenda item 5 partial amendment AoA EN informal Translation | |
| 2024 AGM Agenda item 6 partial amendment AoA NL | |
| 2024 AGM Agenda item 6 partial amendment AoA EN informal Translation | |
| 2024 AGM Agenda item 9 draft of the amended remunaration policy | |
| 2023 Annual Report | |
| Presentation of the AGM (with voting results) held on June 29, 2023 | |
| Minutes of the AGM held on June 29, 2023 | |
Notice is hereby given that the annual general meeting of shareholders (the General Meeting) of TME Pharma N.V. (the Company) is convened at 13.30 hours (CEST) on 29 June 2023 at the offices of Freshfields Bruckhaus Deringer LLP, Strawinskylaan 10, 1077 XZ in Amsterdam, the Netherlands. The language of the meeting shall be English.
The full agenda for the meeting as well as all ancillary documents relevant for the meeting are available for download below.
Downloads
| 2023 AGM Notice and Agenda | |
| 2023 AGM Attendance Notice and PoA | |
| 2023 AGM Agenda item 6 partial amendment AoA NL | |
| 2023 AGM Agenda item 6 partial amendment AoA EN informal Translation | |
| 2022 Annual Report | |
| Minutes of the EGM held on January 30, 2023 | |
Notice is hereby given that the extraordinary general meeting of shareholders (the General Meeting) of TME Pharma N.V. (the Company) is convened at 13.30 (CET) on 30 January 2023 at the offices of Freshfields Bruckhaus Deringer LLP, Strawinskylaan 10, 1077 XZ in Amsterdam, the Netherlands. The language of the meeting shall be English.
The full agenda for the meeting as well as all ancillary documents relevant for the meeting are available for download below.
Downloads
| 2023 EGM Notice and Agenda | |
| 2023 EGM Attendance Notice and PoA | |
| 2023 EGM Agenda item 2 partial amendment AoA NL | |
| 2023 EGM Agenda item 2 partial amendment AoA EN informal translation | |
| 2023 EGM Agenda item 3 partial amendment AoA NL | |
| 2023 EGM Agenda item 3 partial amendment AoA EN informal translation | |
| Presentation of the AGM (with voting results) held on June 29, 2022 | |
| Minutes of the AGM held on June 29, 2022 | |
Notice is hereby given that the annual general meeting of shareholders (the General Meeting) of NOXXON Pharma N.V. (the Company) is convened at 14.00 hours (CEST) on 29 June 2022 at the offices of Freshfields Bruckhaus Deringer LLP, Strawinskylaan 10, 1077 XZ in Amsterdam, the Netherlands. The language of the meeting shall be English.
The full agenda for the meeting as well as all ancillary documents relevant for the meeting are available for download below.
Downloads
| 2022 AGM Notice and Agenda | |
| 2022 AGM Attendance Notice and PoA | |
| 2022 AGM Agenda item 6,7,8 partial amendment AoA NL | |
| 2022 AGM Agenda item 6,7,8 partial amendment AoA EN informal Translation | |
| 2021 Annual Report | |
| Minutes of the EGM held on May 16, 2022 | |
Notice is hereby given that the extraordinary general meeting of shareholders (the “General Meeting”) of NOXXON Pharma N.V. (the “Company”) is convened at 13.30 hours (CET) on 16 May 2022 at the offices of Freshfields Bruckhaus Deringer LLP, Strawinskylaan 10, 1077 XZ in Amsterdam, the Netherlands. The language of the meeting shall be English.
The full agenda for the meeting as well as all ancillary documents relevant for the meeting are available for download below.
Downloads
| 2022 EGM Notice and Agenda | |
| 2022 EGM Attendance Notice and PoA | |
| 2022 EGM Agenda item 2 partial amendment AoA NL | |
| 2022 EGM Agenda item 2 partial amendment AoA EN informal translation | |
| Minutes of the EGM held on December 15, 2021 | |
Notice is hereby given that the extraordinary general meeting of shareholders (the “General Meeting”) of NOXXON Pharma N.V. (the “Company”) is convened at 15.00 hours (CET) on 15 December 2021 at the offices of Freshfields Bruckhaus Deringer LLP, Strawinskylaan 10, 1077 XZ in Amsterdam, the Netherlands. The language of the meeting shall be English.
In light of the public health risks arising from outbreak of the COVID-19 virus and restrictive measures in the Netherlands and elsewhere implemented to reduce gatherings of people, the Company urges its shareholders not to attend the General Meeting in person. You do not need to be present to cast your vote at the General Meeting on 15 December 2021. Instead, please give your voting instructions by proxy. Further details on proxy voting are given in the Attendance Notice for this General Meeting available on this website.
The Company acknowledges that constraints caused by the outbreak of COVID-19 restrict the physical presence of its shareholders at the General Meeting on 15 December 2021 and thus to ask questions at the General Meeting. For this reason, shareholders who decide not to attend the General Meeting on 15 December 2021 in Amsterdam, the Netherlands, and who wish to submit questions regarding items on the agenda of the General Meeting, may submit their questions by email to
The full agenda for the meeting as well as all ancillary documents relevant for the meeting are available for download below.
Downloads
| 2021 EGM Notice and Agenda | |
| 2021 EGM Attendance Notice and PoA | |
| 2021 Main terms of employment for Bryan Jennings | |
| Presentation of the AGM (with voting results) held on June 24, 2021 | |
| Minutes of the AGM held on June 24, 2021 | |
Notice is hereby given that the annual general meeting of shareholders (the General Meeting) of NOXXON Pharma N.V. (the Company) is convened at 14.00 hours (CEST) on 24 June 2021 at the offices of Freshfields Bruckhaus Deringer LLP, Strawinskylaan 10, 1077 XZ in Amsterdam, the Netherlands. The language of the meeting shall be English.
In light of the public health risks arising from outbreak of the COVID-19 virus and restrictive measures in the Netherlands and elsewhere implemented to reduce gatherings of people, the Company urges its shareholders not to attend the General Meeting in person. You do not need to be present to cast your vote at the General Meeting on 24 June 2021. Instead, please give your voting instructions by proxy. Further details on proxy voting are given in the Attendance Notice for this General Meeting available on this website.
The Company acknowledges that constraints caused by the outbreak of the COVID-19 virus restrict the physical presence of its shareholders at the General Meeting on 24 June 2021 and thus to ask questions at the General Meeting. For this reason, shareholders who decide not to attend the General Meeting on 24 June 2021 in Amsterdam, the Netherlands, and who wish to submit questions regarding items on the agenda of the General Meeting, may submit their questions by email to
The full agenda for the meeting as well as all ancillary documents relevant for the meeting are available for download below.
Downloads
| 2021 AGM Notice and Agenda | |
| 2021 AGM Attendance Notice and PoA | |
| 2021 AGM Agenda item 6 partial amendment AoA NL | |
| 2021 AGM Agenda item 6 partial amendment AoA EN informal Translation | |
| 2021 AGM Agenda item 7 partial amendment AoA NL | |
| 2021 AGM Agenda item 7 partial amendment AoA EN informal Translation | |
| 2020 Annual Report | |
| Presentation of the AGM (with voting results) held on June 30, 2020 | |
| Minutes of the AGM held on June 30, 2020 | |
Notice is hereby given that the annual general meeting of shareholders (the General Meeting) of NOXXON Pharma N.V. (the Company) is convened at 10.30 hours (CEST) on 30 June 2020 at the offices of Freshfields Bruckhaus Deringer LLP, Strawinskylaan 10, 1077 XZ in Amsterdam, the Netherlands.
In light of the public health risks arising from outbreak of COVID-19 and restrictive measures in the Netherlands and elsewhere implemented to reduce gatherings of people, the Company urges its shareholders not to attend the General Meeting in person. You do not need to be present to cast your vote at the General Meeting on 30 June 2020. Instead, please give your voting instructions by proxy. Further details on proxy voting are given in the Attendance Notice for this General Meeting available on this website.
The Company acknowledges that constraints caused by the outbreak of COVID-19 restrict the physical presence of its shareholders at the General Meeting on 30 June 2020 and thus to ask questions at the General Meeting. For this reason, shareholders who decide not to attend the General Meeting on 30 June 2020 in Amsterdam, the Netherlands, and who wish to submit questions regarding items on the AGM agenda, may submit their questions by email to
The full agenda for the meeting as well as all ancillary documents relevant for the meeting are available for download below.
Downloads
| 2020 AGM Notice and Agenda | |
| 2020 AGM Attendance Notice and PoA | |
| 2020 AGM Partial Amendment AoA | |
| 2019 Annual Report | |
| Minutes of the AGM held on June 25, 2019 | |
Notice is hereby given that the General Meeting of Shareholders (the General Meeting) of NOXXON Pharma N.V. (the Company) is convened at 13.30 hours (CEST) on June 25, 2019 at the offices of Freshfields Bruckhaus Deringer LLP, Strawinskylaan 10, 1077 XZ in Amsterdam, the Netherlands.
The full agenda for the meeting as well as all ancillary documents relevant for the meeting are available for download below.
Downloads
| 2019 AGM Notice and Agenda | |
| 2019 AGM Attendance Notice and PoA | |
| 2018 Annual Report | |
| Minutes of the EGM held on January 02, 2019 | |
Notice is hereby given that an extra-ordinary general meeting of shareholders (the EGM) of NOXXON Pharma N.V. (the Company) is convened at 13.30 hours (CET) on January 02, 2019 at the offices of Freshfields Bruckhaus Deringer LLP, Strawinskylaan 10, 1077 XZ in Amsterdam, the Netherlands.
The full agenda for the meeting as well as all ancillary documents relevant for the meeting are available for download below.
Downloads
| 2019 EGM Notice and Agenda | |
| 2019 EGM Attendance Notice and PoA | |
| 2019 EGM Agenda item 2-5 partial amendment AoA NL | |
| 2019 EGM Agenda item 2-5 partial amendment AoA EN informal Translation | |
| Minutes of the AGM held on June 20, 2018 | |
Notice is hereby given that the General Meeting of Shareholders (the General Meeting) of NOXXON Pharma N.V. (the Company) is convened at 13.30 hours (CEST) on June 20, 2018 at the offices of Freshfields Bruckhaus Deringer LLP, Strawinskylaan 10, 1077 XZ in Amsterdam, the Netherlands.
The full agenda for the meeting as well as all ancillary documents relevant for the meeting are available for download below.
Downloads
| 2018 AGM Notice and Agenda | |
| 2018 AGM Attendance Notice and PoA | |
| 2018 AGM Agenda item 6 partial amendment AoA NL | |
| 2018 AGM Agenda item 6 partial amendment AoA EN informal Translation | |
| 2017 Annual Report | |
| Minutes of the EGM held on April 24,2018 | |
Notice is hereby given that an extra-ordinary general meeting of shareholders (the EGM) of NOXXON Pharma N.V. (the Company) is convened at 13.30 hours (CEST) on April 24, 2018 at the offices of Freshfields Bruckhaus Deringer LLP, Strawinskylaan 10, 1077 XZ in Amsterdam, the Netherlands.
The full agenda for the meeting as well as all ancillary documents relevant for the meeting are available for download below.
Downloads
| 2018 EGM Notice and Agenda | |
| 2018 EGM Attendance Notice and PoA | |
| 2018 EGM Agenda item 2 partial amendment AoA NL | |
| 2018 EGM Agenda item 2 partial amendment AoA EN informal Translation | |
| Minutes of the AGM held on June 27, 2017 | |
Notice is hereby given that the General Meeting of Shareholders (the General Meeting) of NOXXON Pharma N.V. (the Company) is convened at 13.30 hours (CET) on June 27, 2017 at the offices of Freshfields Bruckhaus Deringer LLP, Strawinskylaan 10, 1077 XZ in Amsterdam, the Netherlands.
The full agenda for the meeting as well as all ancillary documents relevant for the meeting are available for download below.
Downloads
| 2017 AGM Notice and Agenda | |
| 2017 AGM Attendance Notice and PoA | |
| 2017 AGM Agenda item 4 partial amendment AoA NL | |
| 2017 AGM Agenda item 4 partial amendment AoA EN informal Translation | |
| 2016 Annual Report | |
NOXXON Pharma N.V. announced today that it will hold its annual general meeting of shareholders (“AGM”) on June 27, 2017 in Amsterdam, the Netherlands.
The 2016 annual accounts including the annual report, a formal notice convening the AGM, the agenda of the AGM, the explanatory notes to the agenda, the instructions to participate and vote at the AGM, and other AGM documents will be available on the company’s website (www.noxxon.com) as soon as possible and no later than 15 days prior to the date of the AGM. These documents will also be available at the company's offices at Max-Dohrn-Strasse 8-10, 10589 Berlin, Germany, for shareholders and persons entitled to attend the meeting who, upon request, will receive a copy free of charge. The board of directors has decided that it will apply a registration date for the determination of the persons entitled to attend and to vote at the AGM, which date is the 28th day prior to the AGM pursuant to Dutch law. To be eligible to attend and to vote at the AGM, persons must be registered as shareholder in one of the administration records of the intermediaries that are (indirectly) participants in Euroclear France on May 30, 2017 (the “Registration Date”) after all debit and credit entries have been handled as per the Registration Date.
| Minutes of the AGM held on December 22, 2016 | |
Notice is hereby given that the General Meeting of Shareholders (the General Meeting) of NOXXON Pharma N.V. (the Company) is convened at 13.30 hours (CET) on December 22, 2016 at the offices of Freshfields Bruckhaus Deringer LLP, Strawinskylaan 10, 1077 XZ in Amsterdam, the Netherlands.
The full agenda for the meeting as well as all ancillary documents relevant for the meeting are available for download below.
Downloads
| 2016 AGM Notice and Agenda | |
| 2016 AGM Attendance Notice and PoA | |
| 2015 NOXXON Pharma N.V. IFRS | |